Learning Objectives:

1.  To recognize the subtypes of clinical myasthenia gravis.

2.  To know the indications for ordering various Myasthenia antibodies.

3.  To understand the risks and benefits of old and new Myasthenia Gravis treatments.

Session date: 
12/12/2023 - 8:00am to 9:00am CST
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Megan Shanks, MD